Alpha-1-antitrypsin deficiency – PI*Z (p.Glu366Lys) and PI*S (p. Glu288Val) alleles in the SERPINA1 gene
Material:
Quick test description:
Test details:
The SERPINA1 gene encodes the protein alpha-1 antitrypsin (AAT) produced in the liver. This protein protects the bronchi and lungs from damage caused by enzymes (mainly elastase and collagenase) that produce white blood cells in the respiratory system defence against infections and other foreign substances. The congenital deficiency of alpha-1-antitrypsin is a genetic disorder.
The SERPINA1 gene mutation leads either to the accumulation of altered (dysfunctional) AAT in the liver or to a marked reduction in AAT production. Symptoms of accumulating AAT deficiency can manifest at birth with prolonged neonatal jaundice. Liver damage in some cases escalates and requires a liver transplant in childhood. Signs of deficiency may occur when the formation of an effective form of AAT is reduced below 30% of the norm. The reduction of AAT production is manifested mainly in respiratory damage, chronic obstructive pulmonary disease (COPD) and emphysema in adulthood. Liver involvement (cirrhosis, tumours) and skin manifestations are less common. The degree of lung damage depends on past infections and prolonged contact with inhaled pollutants, e.g. working in dusty environments or smoking.
AAT deficiency can manifest and treat as asthma. We use Sanger sequencing to detect PI*Z (p.Glu366Lys) and PI*S (p. Glu288Val) alleles.